Literature DB >> 24713432

Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma.

Clare C Davies1, Emma Harvey2, Raymond F T McMahon2, Katherine G Finegan2, Frances Connor2, Roger J Davis2, David A Tuveson2, Cathy Tournier1.   

Abstract

The c-Jun N-terminal protein kinase (JNK) and its two direct activators, namely the mitogen-activated protein kinase (MAPK) kinase 4 (MKK4) and MKK7, constitute a signaling node frequently mutated in human pancreatic ductal adenocarcinoma (PDAC). Here we demonstrate the cooperative interaction of endogenous expression of Kras(G12D) with loss-of-function mutations in mkk4 or both, mkk4 and mkk7 genes in the pancreas. More specifically, impaired JNK signaling in a subpopulation of Pdx1-expressing cells dramatically accelerated the appearance of Kras(G12D)-induced acinar-to-ductal metaplasia and pancreatic intraepithelial neoplasias, which rapidly progressed to invasive PDAC within 10 weeks of age. Furthermore, inactivation of mkk4/mkk7 compromised acinar regeneration following acute inflammatory stress by locking damaged exocrine cells in a permanently de-differentiated state. Therefore, we propose that JNK signaling exerts its tumor suppressive function in the pancreas by antagonizing the metaplastic conversion of acinar cells toward a ductal fate capable of responding to oncogenic stimulation. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24713432      PMCID: PMC4058314          DOI: 10.1158/0008-5472.CAN-13-2941

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

2.  Notch signalling controls pancreatic cell differentiation.

Authors:  A Apelqvist; H Li; L Sommer; P Beatus; D J Anderson; T Honjo; M Hrabe de Angelis; U Lendahl; H Edlund
Journal:  Nature       Date:  1999-08-26       Impact factor: 49.962

3.  The role of JNK in the development of hepatocellular carcinoma.

Authors:  Madhumita Das; David S Garlick; Dale L Greiner; Roger J Davis
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

4.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Authors:  Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

5.  Suppression of p53-dependent senescence by the JNK signal transduction pathway.

Authors:  Madhumita Das; Feng Jiang; Hayla K Sluss; Chao Zhang; Kevan M Shokat; Richard A Flavell; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

6.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

7.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.

Authors:  T Smeal; B Binetruy; D A Mercola; M Birrer; M Karin
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

8.  MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence.

Authors:  Teiji Wada; Nicholas Joza; Hai-ying M Cheng; Takehiko Sasaki; Ivona Kozieradzki; Kurt Bachmaier; Toshiaki Katada; Martin Schreiber; Erwin F Wagner; Hiroshi Nishina; Josef M Penninger
Journal:  Nat Cell Biol       Date:  2004-02-22       Impact factor: 28.824

9.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

10.  Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.

Authors:  Karen M Mann; Jerrold M Ward; Christopher Chin Kuan Yew; Anne Kovochich; David W Dawson; Michael A Black; Benjamin T Brett; Todd E Sheetz; Adam J Dupuy; David K Chang; Andrew V Biankin; Nicola Waddell; Karin S Kassahn; Sean M Grimmond; Alistair G Rust; David J Adams; Nancy A Jenkins; Neal G Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

View more
  13 in total

Review 1.  Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Ye Shen; Taylor J Chen; H Daniel Lacorazza
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

2.  Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.

Authors:  Irina A Vasilevskaya; Muthu Selvakumaran; Lucia Cabal Hierro; Sara R Goldstein; Jeffrey D Winkler; Peter J O'Dwyer
Journal:  Clin Cancer Res       Date:  2015-05-28       Impact factor: 12.531

3.  The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.

Authors:  Patrick M Grierson; Paarth B Dodhiawala; Yi Cheng; Timothy Hung-Po Chen; Iftikhar Ali Khawar; Qing Wei; Daoxiang Zhang; Lin Li; John Herndon; Joseph B Monahan; Marianna B Ruzinova; Kian-Huat Lim
Journal:  Sci Transl Med       Date:  2021-12-01       Impact factor: 19.319

4.  Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy.

Authors:  Matthew B Lipner; Xianlu L Peng; Chong Jin; Yi Xu; Yanzhe Gao; Michael P East; Naim U Rashid; Richard A Moffitt; Silvia G Herrera Loeza; Ashley B Morrison; Brian T Golitz; Cyrus Vaziri; Lee M Graves; Gary L Johnson; Jen Jen Yeh
Journal:  JCI Insight       Date:  2020-04-23

5.  Dysregulated SREBP1c/miR-153 signaling induced by hypertriglyceridemia worsens acute pancreatitis and delays tissue repair.

Authors:  Juanjuan Dai; Mingjie Jiang; Yangyang Hu; Jingbo Xiao; Bin Hu; Jiyao Xu; Xiao Han; Shuangjun Shen; Bin Li; Zengkai Wu; Yan He; Yingchun Ren; Li Wen; Xingpeng Wang; Guoyong Hu
Journal:  JCI Insight       Date:  2021-01-25

Review 6.  In vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression.

Authors:  Miki Kamiyama; Isao Naguro; Hidenori Ichijo
Journal:  Cancer Sci       Date:  2015-05-25       Impact factor: 6.716

Review 7.  GEMMs as preclinical models for testing pancreatic cancer therapies.

Authors:  Aarthi Gopinathan; Jennifer P Morton; Duncan I Jodrell; Owen J Sansom
Journal:  Dis Model Mech       Date:  2015-10-01       Impact factor: 5.758

8.  Spatio-temporal expression pattern and role of the tight junction protein MarvelD3 in pancreas development and function.

Authors:  Charlotte Heymans; Ophélie Delcorte; Catherine Spourquet; Mylah Villacorte-Tabelin; Sébastien Dupasquier; Younes Achouri; Siam Mahibullah; Pascale Lemoine; Maria S Balda; Karl Matter; Christophe E Pierreux
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

9.  The MKK7 p.Glu116Lys Rare Variant Serves as a Predictor for Lung Cancer Risk and Prognosis in Chinese.

Authors:  Fuman Qiu; Lei Yang; Xiaoxiao Lu; Jiansong Chen; Di Wu; Yongfang Wei; Qingqing Nong; Lisha Zhang; Wenxiang Fang; Xiaoliang Chen; Xiaoxuan Ling; Binyao Yang; Xin Zhang; Yifeng Zhou; Jiachun Lu
Journal:  PLoS Genet       Date:  2016-03-30       Impact factor: 5.917

10.  JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.

Authors:  Alejandro Recio-Boiles; Matthias Ilmer; P Robyn Rhea; Claudia Kettlun; Mitja L Heinemann; Jennifer Ruetering; Jody Vykoukal; Eckhard Alt
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.